Free Trial
LON:KRM

KRM22 (KRM) Share Price, News & Analysis

KRM22 logo
GBX 24.50 0.00 (0.00%)
As of 02/21/2025

About KRM22 Stock (LON:KRM)

Key Stats

Today's Range
24.50
25
50-Day Range
24.55
30
52-Week Range
15
35
Volume
152 shs
Average Volume
12,528 shs
Market Capitalization
£9.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

At KRM22, we believe in a world in which organisations operate at their optimal threshold of risk to drive increased returns. We develop outstanding products built and delivered through a Global Risk Platform, to bring increased visibility and lower cost management to capital market organisations.

Receive KRM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for KRM22 and its competitors with MarketBeat's FREE daily newsletter.

KRM Stock News Headlines

Bill Gates’ is about to mint millionaires (again) with Stargate.
This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.
Portfolio Update
See More Headlines

KRM Stock Analysis - Frequently Asked Questions

KRM22's stock was trading at GBX 27.50 at the beginning of 2025. Since then, KRM shares have decreased by 10.9% and is now trading at GBX 24.50.
View the best growth stocks for 2025 here
.

Shares of KRM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that KRM22 investors own include Intel (INTC), Alibaba Group (BABA), B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR) and Greencore Group (GNC).

Industry, Sector and Symbol

Industry
Asset Management
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
45
Year Founded
N/A

Profitability

Net Income
£-2,535,493.66
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£3.07 million
Cash Flow
GBX 5.10 per share
Book Value
GBX (3.11) per share

Miscellaneous

Free Float
N/A
Market Cap
£9.29 million
Optionable
Not Optionable
Beta
-0.15
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report

This page (LON:KRM) was last updated on 2/23/2025 by MarketBeat.com Staff
From Our Partners